Real‐world clinical features, health‐care utilization, and economic burden in decompensated cirrhosis patients: A national database

Patients with decompensated cirrhosis are well known to experience morbidity and mortality.

[1]  E. Tapper,et al.  Review article: current and emerging therapies for the management of cirrhosis and its complications , 2022, Alimentary pharmacology & therapeutics.

[2]  D. Rockey,et al.  Improved Mortality But Increased Economic Burden of Disease in Compensated and Decompensated Cirrhosis , 2021, Journal of Clinical Gastroenterology.

[3]  N. Hotta,et al.  Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis , 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  Y. Lim,et al.  Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma , 2021, Clinical and molecular hepatology.

[5]  H. Yu,et al.  Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry , 2021, Clinical and molecular hepatology.

[6]  P. Angeli,et al.  Changes in the epidemiology and management of bacterial infections in cirrhosis , 2021, Clinical and molecular hepatology.

[7]  Samuel S. Lee,et al.  β-blockers in advanced cirrhosis: More friend than enemy , 2020, Clinical and molecular hepatology.

[8]  R. Gani,et al.  Managing liver cirrhotic complications: Overview of esophageal and gastric varices , 2020, Clinical and molecular hepatology.

[9]  D. J. Kim,et al.  Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017 , 2019, Clinical and molecular hepatology.

[10]  E. Ingelsson,et al.  A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA , 2019, Digestive Diseases and Sciences.

[11]  M. Boustani,et al.  Increasing Economic Burden in Hospitalized Patients With Cirrhosis: Analysis of a National Database , 2019, Clinical and translational gastroenterology.

[12]  J. M. Kim,et al.  Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation , 2019, Clinical and molecular hepatology.

[13]  G. Dusheiko,et al.  Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B. , 2019, Journal of hepatology.

[14]  P. Kamath,et al.  Increasing Health Care Burden of Chronic Liver Disease Compared With Other Chronic Diseases, 2004-2013. , 2018, Gastroenterology.

[15]  Hwa Young Choi,et al.  Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims’ Data , 2017, Gut and liver.

[16]  M. Stepanova,et al.  Direct and Indirect Economic Burden of Chronic Liver Disease in the United States , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  J. Jang,et al.  Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea , 2016, Medicine.

[18]  A. Barritt,et al.  Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. , 2015, Gastroenterology.

[19]  L. Kim,et al.  A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples , 2014, Epidemiology and health.

[20]  S. Park.  KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease , 2013, Clinical and molecular hepatology.

[21]  Bing Li,et al.  Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. , 2011, American journal of epidemiology.

[22]  G. Marchesini,et al.  Factors associated with poor health-related quality of life of patients with cirrhosis. , 2001, Gastroenterology.

[23]  A. B. Sukhomlinov,et al.  [Liver cirrhosis]. , 1989, Fel'dsher i akusherka.